1. Metabolic Drug Interactions with Immunosuppressants
   Katalin Monostory, 2018 CrossRef
2. Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients
   Minji Sohn et al, 2018, Sci Rep CrossRef
3. Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis
   Shinji Okabayashi et al, 2019, Intest Res CrossRef
4. Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
   Jie Tang et al, 2017, Sci Rep CrossRef
5. Advances in the Mechanism of Cytochrome P450 on Organ Transplantation
   若菡 张, 2021, ACM CrossRef
6. Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
   Valentina Urzì Brancati et al, 2022, Biomedicines CrossRef
7. Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone
   Tamás Resál et al, 2023, Expert Opinion on Drug Safety CrossRef
8. The Impact of ABCB1 SNPs on Tacrolimus Pharmacokinetics in Liver or Kidney Transplant Recipients: A Meta-analysis
   Ze Li et al, 2023, CPD CrossRef
9. Descripción de polimorfismos genéticos en CYP3A5 y MDR-1 y su impacto en el rechazo agudo clínico de pacientes trasplantados de hígado del Hospital San Vicente Fundación Rionegro
   Lina María Botero-Mora et al, 2024, Rev Colomb Cir CrossRef
10. Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review
    Sadiq Aliyu Hussaini et al, 2024, Pharmacogenomics CrossRef